Major Findings From Marketing Research Study On Hair Loss Conducted By Lexington International

Dec. 16, 2009 - PRLog -- Boca Raton, FL. Lexington Intl, manufacturer of the HairMax LaserComb, the only laser phototherapy device cleared for marketing by the FDA, announces the findings of a major 12 month study on hair loss. Over 4,500 male and female consumers responded to the survey which generated a wealth of data on peoples’ perception of hair loss and the actions they took to treat their condition.  Respondents were asked to complete a 16 question multiple choice survey and were also asked to provide open ended comments at the end.  Data generated from the study by age of respondents mirrored the incidence of hair loss found in the general population.

Treatment Patterns

One of the main goals of the survey was to discover which factors influenced their decision to treat their hair loss and what action they took. While the result showed, as expected that over two thirds of respondents were ‘dissatisfied with their appearance’, almost 40% of respondents indicated that lack of confidence or a ‘negative impact on social or job situations’ was a key factor in seeking treatment.  The findings also highlighted how important it is for physicians to become fully knowledgeable about the device as over 45% of respondents visited a doctor and of these 41% sought advice from a dermatologist.  Finally, the study confirmed the cost involved in treating hair loss in that while almost two third of respondents indicated that they spend up to $25 a month in treatment for their hair, almost 20% spend up to $50 per month.  Of those who purchased products to treat their hair loss, almost 50% purchased minoxidil, while almost 40% had purchased vitamins and herbal supplements in an effort to try to ameliorate their condition.

Perception of Information

Lexington also sought to understand what factors motivated individuals to purchase the HairMax LaserComb.  In this age of electronic media, it was no surprise that over 50% of respondents found information on the HairMax either from a search engine or other web sites.  While many people now question the value of newspapers or magazine as a source of information, the survey showed that one quarter of respondents heard about the device from newspapers and magazines.  Lexington has devoted tremendous resources to assure that the HairMax website, www.hairmax.com  has high value and motivation.  The survey validated these efforts as the site was found to be highly informative, provided useful information, and motivational to purchase by two thirds of respondents.

Since the HairMax is a one time purchase that has an expected lifetime of over 10 years and does not require the purchase of other ancillary products,  a key question in the questionnaire related to the perceived value of the HairMax relative to price.  Overall, respondents indicated that the information people found about the HairMax made them “recognize the HairMax LaserComb as a tremendous value long-term”.  The money back guarantee for the device also was found to be a major determinant in the decision to purchase the HairMax by over 40% of respondents.  Since the HairMax is the only laser phototherapy device for hair growth cleared for marketing by the FDA, over 30% indicated  this imprimatur was a major factor that influenced them to purchase the device.

Leonard Stillman, Director of Professional Services said:  “This study provided meaningful data on patients’ perception and actions taken to treat their hair loss. Most importantly, the survey clearly pointed out the need people have for information on hair loss, and the fact that the web site for the HairMax answered this need”.

Lexington will continue to be diligent in its marketing efforts for the HairMax to asure that information about the device is informative and valuable to the many million of people who suffer from hair loss around the world.

About Lexington International, LLC  

Based in Boca Raton, Lexington International is a manufacturer and developer of advanced medical laser devices to treat hair loss and scalp disorders.  Lexington International markets the only laser phototherapy device cleared for marketing by the FDA to promote hair growth in men suffering from certain classes of Androgenetic Alopecia.  The company, was one of just 14 leading manufacturing exporting companies nationwide to receive the 2009 U.S. President’s “E” Award, which recognizes successes in world markets and subsequent contributions to the U.S. economy.  Over the past 8 years and in over 125 countries worldwide, Lexington Int., LLC has helped hundreds of thousands of individuals improve their appearances with innovative products to treat their hair.  (www.hairmax.com)